Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

Pfizer Inc.

PFENYSE
Healthcare
Drug Manufacturers - General
$26.86
$0.001(0.004%)
U.S. Market opens in 1h 33m

Pfizer Inc. (PFE) Stock Overview

Explore Pfizer Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap151.6B
P/E Ratio19.43
EPS (TTM)$1.36
ROE0.09%
Fundamental Analysis

AI Price Forecasts

1 Month$27.79
3 Months$26.74
1 Year Target$24.22

PFE Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Pfizer Inc. (PFE) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 50.79, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $24.22.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 19.43 and a market capitalization of 151.6B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-0.69%
5-Day Change
-3.35%
1-Month Change
4.53%
3-Month Change
9.32%
6-Month Change
5.10%
Year-to-Date (YTD) Change
5.94%
1-Year Change
2.99%
3-Year Change
-37.53%
5-Year Change
-22.14%
All-Time (Max) Change
6110.28%

Contact Information

212 733 2323
235 East 42nd Street, New York City, NY, 10017

Company Facts

810,000 Employees
IPO DateJun 1, 1972
CountryUS
Actively Trading

Frequently Asked Questions